CAMP4 Therapeutics Corporation Increase Decrease In Operating Lease Liability
CAMP4 Therapeutics Corporation (CAMP) reported Increase Decrease In Operating Lease Liability of $19.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-13
- 2026-06-30: Increase Decrease In Operating Lease Liability 6 month $19.00K.
- 2025-06-30: Increase Decrease In Operating Lease Liability 6 month -$1.45M.
| Period end | Increase Decrease In Operating Lease Liability 6 month |
|---|---|
| 2026-06-30 | $19.00K 10-Q · filed 2026-08-13 |
| 2025-06-30 | -$1.45M 10-Q · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |